These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia. Venditti A; Piciocchi A; Candoni A; Melillo L; Calafiore V; Cairoli R; de Fabritiis P; Storti G; Salutari P; Lanza F; Martinelli G; Luppi M; Mazza P; Martelli MP; Cuneo A; Albano F; Fabbiano F; Tafuri A; Chierichini A; Tieghi A; Fracchiolla NS; Capelli D; Foà R; Alati C; La Sala E; Fazi P; Vignetti M; Maurillo L; Buccisano F; Del Principe MI; Irno-Consalvo M; Ottone T; Lavorgna S; Voso MT; Lo-Coco F; Arcese W; Amadori S Blood; 2019 Sep; 134(12):935-945. PubMed ID: 31395600 [TBL] [Abstract][Full Text] [Related]
7. An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation. Ferguson P; Hills RK; Grech A; Betteridge S; Kjeldsen L; Dennis M; Vyas P; Goldstone AH; Milligan D; Clark RE; Russell NH; Craddock C; Haematologica; 2016 Nov; 101(11):1351-1358. PubMed ID: 27540133 [TBL] [Abstract][Full Text] [Related]
8. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes. Nardi V; Hasserjian RP Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274 [TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98. von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630 [TBL] [Abstract][Full Text] [Related]
10. [Diagnostics and therapy of acute myeloid leukemia]. Bornhäuser M; Ehninger G Dtsch Med Wochenschr; 2009 Sep; 134(39):1935-41. PubMed ID: 19760554 [No Abstract] [Full Text] [Related]
11. Molecular characterization of acute myeloid leukemia and its impact on treatment. Frankfurt O; Licht JD; Tallman MS Curr Opin Oncol; 2007 Nov; 19(6):635-49. PubMed ID: 17906465 [TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia. Rubnitz JE; Gibson B; Smith FO Pediatr Clin North Am; 2008 Feb; 55(1):21-51, ix. PubMed ID: 18242314 [TBL] [Abstract][Full Text] [Related]
15. [Disseminated tuberculosis during induction chemotherapy in acute myeloid leukemia]. Brockhaus L; Brune J; Battegay R; Gerull S; Nägele M; Bättig V Internist (Berl); 2019 Jun; 60(6):634-637. PubMed ID: 30762085 [TBL] [Abstract][Full Text] [Related]
16. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial. Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940 [TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia: 2013 update on risk-stratification and management. Estey EH Am J Hematol; 2013 Apr; 88(4):318-27. PubMed ID: 23526416 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment. Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815 [TBL] [Abstract][Full Text] [Related]
19. [Current treatment options in acute myeloid leukemia]. Heuser M; Schlenk RF; Ganser A Internist (Berl); 2011 Dec; 52(12):1386-93. PubMed ID: 22071913 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis. Limvorapitak W; Barnett MJ; Hogge DE; Forrest DL; Nevill TJ; Narayanan S; Power MM; Nantel SH; Broady R; Song KW; Toze CL; Mourad YA; Sutherland HJ; Gerrie AS; White J; Sanford DS Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e481-e491. PubMed ID: 30100330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]